Drug Type Small molecule drug |
Synonyms EV-200 |
Target |
Action modulators |
Mechanism SIRT1 modulators(NAD-dependent deacetylase sirtuin 1 modulators), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Preclinical | United States | 01 Apr 2026 |





